{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "ARXS",
  "name": "Arxis, Inc.",
  "url": "https://frontierpicks.com/dossiers/ARXS/",
  "json_url": "https://frontierpicks.com/dossiers/ARXS.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Sponsor carve-out compounding into a Defense & Space upcycle, but the 2026-07-29 guide raise to $1.96–1.98B is now in the price. Omnetics closed 2026-08-17 at $770M EV, paid principally in 13.35M Class A shares. Momentum has reset — RSI(14) 48.8 on the 2026-08-21 close of $53.26 versus 73.9 a week earlier — with no confirmed catalyst before the late-October Q3 print.",
  "invalidation_trigger": "A weekly close below $50 unwinds the post-2026-07-29 guidance-raise re-rating and returns price toward RBC's Sector Perform target; secondarily, a late-October Q3 print that reiterates rather than raises the $1.960B-$1.980B FY2026 revenue guide, or a resale registration after the mid-October lock-up window.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "space-economy",
    "freight-logistics",
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Dual-class: Class A 76.8M vs Class B 340.7M as of the Q2 2026 8-K; Arcline retains voting control and the public float is a minority of shares outstanding.",
    "A further 13,351,964 Class A shares were issued 2026-08-17 as Omnetics consideration under a Section 4(a)(2) exemption and are subject to lockup.",
    "Listed on Nasdaq 2026-04-17 at $28.00. With roughly four months of history, 100-day and 200-day moving-average frames do not yet exist for this name.",
    "Guidance and margin figures are non-GAAP. GAAP Q2 2026 was a net loss of $(5)M versus $(29)M a year earlier.",
    "Serial acquirer: MagCanica closed 2026-06-01, Blue Line Engineering 2026-07-29, Omnetics 2026-08-17. Reported growth blends organic and acquired revenue.",
    "IPO lock-up terms are set in the April 2026 prospectus; a release would enlarge a float that is currently a minority of shares outstanding."
  ],
  "body_markdown": "## Current Thesis\nArxis supplies mission-critical interconnect and mechanical components for extreme environments — connectors, cable assemblies, RF/microwave and microelectronic packaging, plus self-lubricating bearings, seals, springs, ducting and radar-absorbing materials — into defense and space, commercial aerospace, medtech and semiconductor test. The narrative leg being bought is a sponsor carve-out compounding into a Defense & Space upcycle at a 40%-plus adjusted EBITDA margin while the sell-side is still building its first models on a company that listed 2026-04-17.\n\nTwo things moved since the prior note dated 2026-08-15. First, the Omnetics acquisition — previously flagged as \"expected Q3 2026\" — closed on 2026-08-17 at an agreed enterprise value of $770.0 million, disclosed in an 8-K filed 2026-08-18. It was paid principally in stock: 13,351,964 Class A shares issued to former Omnetics holders, approximately 3.1% of total common stock as of closing, issued under a Section 4(a)(2) private-placement exemption and subject to lockup, alongside $8.0 million of cash into escrow. Arxis put the combined purchase multiple for Omnetics and MagCanica at approximately 12x FY27 estimated adjusted EBITDA. Second, the price geometry that made the prior note cautious has largely resolved on its own: the reference close on 2026-08-21 was $53.26 against $57.28 on 2026-08-14, RSI(14) fell to 48.8 from 73.9, and the three-month price change moderated to +53.0% from +65.6%.\n\nThe narrative is **maturing**. What dates it — the attention burst ran 2026-07-29 (guide raise) through 2026-08-13 (Citigroup's second raise, to $67), and nothing new has landed on the tape since. The Omnetics close on 2026-08-17/18 was absorbed without a print above the $61.50 post-IPO high. The story is now well known to the desks that cover it, the numbers still work, and the incremental flow has thinned. That is a downgrade from the accelerating label carried on 2026-08-15, and it is a statement about participation, not about the operating results.\n\n## Bull Case\n- **Organic growth is carrying the print.** Q2 2026 (2026-07-29): revenue $501M, +25% YoY with 21% organic. The 4-point wedge between total and organic is small for a company that closed two deals inside the quarter window.\n- **Margin structure.** Q2 adjusted EBITDA $211M, +38%, a 42.2% margin, +390bps YoY; FY26 guided to $790–800M on $1.960–1.980B of revenue (~40.4% at the midpoints, per the company's own guide).\n- **The guide raise was large and early.** FY2026 revenue guidance moved from $1.860–1.880B to $1.960–1.980B on 2026-07-29 — roughly $100M at the midpoint against a guide set only months after the April listing, versus a $1.883B consensus.\n- **Deal currency was equity, and leverage stayed intact.** Omnetics was funded principally with 13,351,964 Class A shares rather than cash or new debt (8-K, 2026-08-18), against net leverage that fell to 1.8x from 4.2x at year-end 2025.\n- **The disclosed deal multiple sits below the multiple the market applies to Arxis itself.** ~12x FY27E adjusted EBITDA for Omnetics plus MagCanica, against a $23.91B market cap (2026-08-14) versus the $790–800M FY26 adjusted EBITDA guide. The comparison is an inference from two disclosed figures, on equity value rather than enterprise value.\n- **Coverage is still forming.** Citigroup $61 (2026-07-31) → $67 (2026-08-13); Wells Fargo Overweight $63 (2026-08-04); RBC Sector Perform $50 (2026-07-31). Consensus average target was $59.90 as of 2026-08-14.\n\n## Bear Case\n- **The in-year raise lever is largely spent.** Management described ~95% of 2026 revenue as already secured at the Q2 materials (2026-07-29), which arithmetically caps what a second raise can contain. The debate moves to 2027 framing the company has not published.\n- **The 12x multiple is on an estimate the company has not disclosed.** The FY27 adjusted EBITDA denominator behind the ~12x combined multiple is a company projection; no Omnetics revenue or EBITDA contribution figure appears in the 8-K.\n- **Share supply now has three sources.** Class A 76.8M versus Class B 340.7M at the Q2 filing, plus 13,351,964 new Class A shares issued 2026-08-17 under lockup, ahead of a customary ~180-day IPO lock-up window that lands near 2026-10-14 (exact terms are in the April 2026 prospectus).\n- **Valuation rests on the guide.** $23.91B market cap (2026-08-14) against $790–800M of guided FY26 adjusted EBITDA; trailing P/E screened at 186.87 on 2026-08-14, distorted by the GAAP net loss of $(5)M in Q2.\n- **Momentum has already given back part of the leg.** From the 2026-08-14 close of $57.28 to $53.26 on 2026-08-21, with RSI(14) down to 48.8. The uptrend is intact against the $28.00 IPO price; the acceleration is not.\n- **Empty near calendar.** No confirmed dated event between now and roughly the third week of September, which leaves the tape to positioning.\n\n## Setup & Price Structure\n- Reference close 2026-08-21: $53.26. Post-IPO range $33.15–$61.50 (as of 2026-08-14). IPO priced at $28.00 on 2026-04-17.\n- Price sits between the $61.50 post-IPO high and the $50 area RBC's Sector Perform target marks (2026-07-31), with the $59.90 consensus average target (2026-08-14) now above the last close.\n- RSI(14) 48.8 on 2026-08-21, from 73.9 on the prior note's reference date of 2026-08-14 — the overbought condition cleared through price and time rather than through a break of the post-guidance range.\n- With the listing dated 2026-04-17, roughly four months of history exists. There is no 100-day or 200-day moving-average frame for this name, so trend-following levels commonly cited elsewhere do not yet apply here.\n- Crowding and positioning observables, stated as observables: three price-target increases inside fifteen days ending 2026-08-13, then silence for eight sessions; a dual-class structure in which the public float is a minority of shares outstanding; a lock-up window approaching in mid-October. No insider Form 4 sales have been identified in the window reviewed.\n\n## Catalyst Calendar (next 30 days)\n- **No confirmed dated company event falls inside the 30 days to ~2026-09-22.** The Omnetics close (2026-08-17, disclosed 2026-08-18) was the last scheduled item and it has passed.\n- **~2026-09-30** — Q3 2026 quarter end. First reporting period to include Omnetics, from the 2026-08-17 closing date.\n- **~2026-10-14 (est.)** — approximately 180 days from the 2026-04-17 IPO; customary lock-up windows run to roughly this mark. Terms are set in the April 2026 prospectus.\n- **~2026-10-28 (est.)** — Q3 FY2026 print. Date unconfirmed; timing inferred from the 2026-07-29 Q2 release cadence.\n\n## What Would Change Our Mind\nThe structure that matters is the range built after the 2026-07-29 guidance raise, and the level that grades it is $50 — RBC's target and the round number beneath the post-raise base. A weekly close below $50 would say the re-rating that followed the raise has been given back, with the last close of $53.26 (2026-08-21) roughly six percent above it. Three further conditions would each change the read independently: the late-October Q3 print reiterating rather than raising the $1.960–1.980B FY2026 revenue guide, or reporting organic growth below the 21% recorded in Q2; a resale registration or marketed secondary after the mid-October lock-up window, which would convert the sponsor's 340.7M Class B holding from an overhang into actual supply; and a widening gap between reported and organic growth at the Q3 or Q4 print, which would show the roll-up carrying the top line. Conversely, a reclaim of $61.50 on volume with a fresh estimate revision would restore the accelerating label the prior note carried.\n\n## Correlation Notes\n- The fundamental linkages are US defense appropriations timing (Defense & Space led Q2 growth per the 2026-07-29 release), commercial aerospace build rates, and the interconnect/aerospace-content complex — Amphenol, Heico, TransDigm, RBC Bearings — where a group de-rating would compress Arxis regardless of its own execution.\n- A continuing resolution extending into FY2027 is the specific macro mechanism that would delay procurement obligations behind the ~95%-secured 2026 revenue figure.\n- With roughly four months of trading since 2026-04-17, any beta or correlation estimate for this name is computed over a very short sample and should be treated as unreliable. What can be said from the record is that the name has traded on its own dated events — the 2026-07-29 print, the 07-31/08-04/08-13 target changes — rather than in sympathy with an index.\n- Recent-IPO supply dynamics are a shared factor with the 2026 listing cohort: a lock-up window near 2026-10-14 puts this name into the same calendar mechanic as other April-2026 listings, which is an inference from the listing date, not a measured relationship.",
  "first_seen": "2026-08-10",
  "last_analyzed": "2026-08-23T12:06:38+00:00",
  "last_synthesized": "2026-08-23",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}